CEO of Javelin Pharmaceuticals Inc (JAV, Financial) Martin J Driscoll buys 6,331 shares of JAV on 02/12/2010 at an average price of $1.27 a share.
Javelin Pharmaceuticals Inc has a market cap of $84.3 million; its shares were traded at around $1.31 with and P/S ratio of 22.1.
JAV is in the portfolios of Jim Simons of Renaissance Technologies LLC.
Javelin Pharmaceuticals Inc has a market cap of $84.3 million; its shares were traded at around $1.31 with and P/S ratio of 22.1.
JAV is in the portfolios of Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Buy:: CEO Martin J Driscoll bought 22,181 shares of JAV stock on 03/19/2010 at the average price of 1.3, the price of the stock has increased by 0.77% since.
- Buy:: CEO Martin J Driscoll bought 6,331 shares of JAV stock on 02/12/2010 at the average price of 1.27, the price of the stock has increased by 3.15% since.
Directors and Officers Recent Trades:
- Buy:: Director Neil Flanzraich bought 84,580 shares of JAV stock on 03/03/2010 at the average price of 1.41, the price of the stock has decreased by 7.09% since.
- Buy:: Director Neil Flanzraich bought 111,000 shares of JAV stock on 02/19/2010 at the average price of 1.42, the price of the stock has decreased by 7.75% since.
- Buy:: Director Neil Flanzraich bought 165,483 shares of JAV stock on 02/16/2010 at the average price of 1.28, the price of the stock has increased by 2.34% since.
